Amplify Weight Loss Drug & Treatment ETF (THNR)

THNR Holdings List

As of Dec 3, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	15.85%	427
2	NVO	Novo Nordisk A/S	10.17%	5,951
3	REGN	Regeneron Pharmaceuticals, Inc.	7.88%	303
4	AMGN	Amgen Inc.	7.57%	610
5	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	7.22%	3,800
6	MRK	Merck & Co., Inc.	5.58%	1,518
7	SWX: ROG	Roche Holding AG	5.39%	383
8	AZN	AstraZeneca PLC	5.20%	1,594
9	ABBV	AbbVie Inc.	4.85%	587
10	PFE	Pfizer Inc.	4.78%	5,200
11	HKG: 1801	Innovent Biologics, Inc.	4.45%	10,500
12	TYO: 4507	Shionogi & Co., Ltd.	4.32%	7,100
13	HKG: 1093	CSPC Pharmaceutical Group Limited	3.55%	100,000
14	HIMS	Hims & Hers Health, Inc.	3.32%	2,497
15	CPH: ZEAL	Zealand Pharma A/S	3.13%	1,130
16	SRRK	Scholar Rock Holding Corporation	2.06%	1,317
17	JNGHF	Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H	1.46%	4,400
18	KRX: 128940	Hanmi Pharm. Co., Ltd.	1.17%	110
19	HKG: 3933	The United Laboratories International Holdings Limited	1.06%	18,000
20	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	0.82%	22,716
21	n/a	OTHER ASSETS AND LIABILITIES	0.13%	99,922,923
22	n/a	JAPANESE YEN	0.05%	231,952

As of Dec 3, 2025